The American Journal of Medicine
Volume 122, Issue 3 , Pages 281-289.e2, March 2009

Staphylococcus Aureus Bacteremia Among Patients with Health Care-associated Fever

Part of this study was presented as a poster at the 45th Annual Interscience Conference on Antimicrobial Agents & Chemotherapy, Washington, DC, December 18th 2005.

  • Martin E. Stryjewski, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno” (CEMIC), Buenos Aires, Argentina
    • Corresponding Author InformationRequests for reprints should be addressed to Martin E. Stryjewski, MD, MHS, Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno”, Azcuenaga 1757, Apt 1C, Capital Federal (C1128AAC), Buenos Aires, Argentina
    • ,
  • Zeina A. Kanafani, MD

      Affiliations

    • Division of Infectious Diseases, American University of Beirut Medical Center, Beirut, Lebanon
    • ,
  • Vivian H. Chu, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Department of Medicine, Duke University Medical Center, Durham, NC
    • ,
  • Paul A. Pappas, MS

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Tina Harding, BSN

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Laura A. Drew, RN, BSN

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Daniel K. Benjamin Jr, MD, PhD, MHS

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Department of Pediatrics, Duke University Medical Center, Durham, NC
    • ,
  • L. Barth Reller, MD

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, NC
    • ,
  • Benjamin A. Lee, BA

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • G. Ralph Corey, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Department of Medicine, Duke University Medical Center, Durham, NC
    • ,
  • Vance G. Fowler Jr, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Department of Medicine, Duke University Medical Center, Durham, NC

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding: This work was supported by a grant from Inhibitex, Inc. Inhibitex did not intervene in: design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.

 Conflicts of Interest: Martin E. Stryjewski has consulted for Astellas (<$10,000), and has received a research grant (>$10,000) and is a consultant for Theravance Inc. (>$10,000/year). Vivian H. Chu has received a research grant from Theravance Inc. Vance G. Fowler has received research funding from Theravance, Merck, Nabi (<US$10,000/year), Inhibitex, Cubist, and the National Institute of Health; is a consultant for Biosynexus, Inhibitex, Merck, Cerexa, and Cubist; and is on the speaker's bureaus for Cubist and Pfizer. G. Ralph Corey has received research funding from Theravance, Cubist, Merck, and Inhibitex; and is a consultant for Cubist, Inhibitex, Cerexa, and Pfizer. Daniel K. Benjamin Jr. has received a research grant from Nabi, Cape Cod Associates, Astellas, MedImmune, Pediatrix, Rockeby, National Institute of Child Health and Human Development, and National Institute of Allergy and Infectious Diseases. Tina Harding, Laura A. Drew, Paul A. Pappas, Benjamin A. Lee, Zeina A. Kanafani, and L. Barth Reller have no conflicts.

 Authorship: All authors had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

PII: S0002-9343(08)01063-2

doi:10.1016/j.amjmed.2008.09.040

The American Journal of Medicine
Volume 122, Issue 3 , Pages 281-289.e2, March 2009

Article Tools

* Image Usage & Resolution